Scorp Bio Medicines Profile
Key Indicators
- Authorised Capital ₹ 6.00 M
as on 17-12-2024
- Paid Up Capital ₹ 4.96 M
as on 17-12-2024
- Company Age 30 Year, 4 Months
- Last Filing with ROC 31 Mar 2013
- Open Charges ₹ 1.23 Cr
as on 17-12-2024
About Scorp Bio Medicines
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2013. It's a company limited by shares with an authorized capital of Rs 6.00 M and a paid-up capital of Rs 4.96 M.
The company currently has active open charges totaling ₹1.23 Cr.
Gonupalli Sudhakar and Gonupillai Neeraja serve as directors at the Company.
- CIN/LLPIN
U24231TN1994PTC028279
- Company No.
028279
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Aug 1994
- Date of AGM
30 Sep 2013
- Date of Balance Sheet
31 Mar 2013
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Scorp Bio Medicines?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gonupalli Sudhakar  | Managing Director | 05-Aug-1994 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Gonupillai Neeraja | Director | 11-Aug-1997 | Current |
Financial Performance of Scorp Bio Medicines.
Enhance accessibility to Scorp Bio Medicines's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Scorp Bio Medicines?
Unlock access to Scorp Bio Medicines's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Seron Pharma Private LimitedActive 23 years 5 monthsGonupalli Sudhakar and Gonupillai Neeraja are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of Mysore Creation Date: 11 Aug 2009 | ₹8.92 M | Open |
Indian Bank Creation Date: 08 Jan 1996 | ₹1.70 M | Open |
Indian Bank Creation Date: 03 Jan 1996 | ₹1.70 M | Open |
How Many Employees Work at Scorp Bio Medicines?
Scorp Bio Medicines has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Scorp Bio Medicines, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Scorp Bio Medicines's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
